Your Article Summary
See Latest ArticlesA systematic review of the cardiovascular risk of inhaled anticholinergics in patients with COPD
International Journal of COPD, 07/01/09
Hilleman DE et al. - The long-term use of inhaled anticholinergic agents has recently been suggested to be associated with an excess risk of adverse cardiovascular (CV) outcomes in patients with COPD. The relative risks for serious CV events, heart failure, and myocardial infarction were all significantly lower with tiotropium than placebo.
Related Articles
Bone mineral density and fractures in older men with chronic obstructive pulmonary disease or asthma
Osteoporosis International, 10/13/09
Relevance Score: 92%
Interaction in COPD experiment (ICE): A hazardous combination of cigarette smoking and bronchodilation in chronic obstructive pulmonary disease
Medical Hypotheses, 10/08/09
Relevance Score: 91%
Molecular Characterization of Chronic Obstructive Pulmonary Disease-Related Non-Small Cell Lung Cancer Through Aberrant Methylation and Alterations of EGFR Signaling
Annals of Surgical Oncology, 10/23/09
Relevance Score: 90%
Tiotropium HandiHaler in the treatment of COPD: A safety review
International Journal of COPD, 10/29/09
Relevance Score: 89%
Living with advanced chronic obstructive pulmonary disease: patients concerns regarding death and dying
Palliative Medicine, 10/16/09
Relevance Score: 89%
Today in COPD...keeping you current
Receive free subspecialty "5-minute updates" via email
Low Erythropoietin Plasma Levels during Exacerbations of COPD
Respiration, 12/16/09
Measuring exacerbations in obstructive lung disease
Pharmacoepidemiology and Drug Safety, 12/16/09
The Hedgehog interacting protein is a COPD susceptibility gene: the Rotterdam Study
European Respiratory Journal , 12/15/09